4/A

OWNERSHIP DOCUMENT

Company: Anika Therapeutics, Inc.
Filed: August 8, 2013
Period of Report: August 6, 2013
Accession Number: 0001144204-13-044106

View Document ↗ View on SEC.gov ↗